Verbatim response from Claude
Zepbound vs. Compounded Tirzepatide: Is the Brand Worth It?
Quick Answer
It depends on your situation, but here's an honest breakdown:
Arguments FOR Zepbound (Brand)
- Eli Lilly's quality control — consistent dosing, sterility, standardized manufacturing
- FDA-approved with proven clinical trial data
- Lilly's savings card can bring cost to ~$550/month if you have commercial insurance, or $699/month self-pay through LillyDirect
- Auto-injector pens are convenient and reliable
- Lower legal/regulatory risk — compounding rules are shifting
Arguments FOR Compounded Tirzepatide
- Often $150–$400/month through telehealth platforms
- Popular providers: Hims & Hers, eMed, Ro, Henry Meds, Nuvation
- Same active molecule when done correctly
- Practical choice when brand is unaffordable
Key Concerns About Compounding
- Quality varies significantly by pharmacy
- The FDA has flagged some compounders
- Now that Zepbound shortage is resolved, compounding legal status is uncertain
- Stick to 503B outsourcing facilities if you go this route
My Recommendation
- Can afford ~$550-700/month? → Go with Zepbound
- Budget is the barrier? → Compounded can work, but choose a reputable telehealth platform using verified pharmacies
Always consult your doctor about which option suits your health situation.